Start-up
The role of fatty liver in the epidemic of advanced chronic liver disease among people living with HIV
Learn MoreStart-up
Drug-drug interaction study between bictegravir/emtricitabine/tenofovir alafenamide and feminizing hormones in trans women living with HIV
Learn MoreOngoing
Optimising Outcomes at Critical Points in the Cascade of HIV Care in Ontario
Learn MoreEnrolling
Immunogenicity outcomes in people living with HIV following vaccination for COVID-19 (HIV-COV)
Learn MoreEnrolling
The impact of COVID-19 on persons with HIV in Canada: Data from the HIV/HCV co-infection/CCC (CTN 222) and HIV aging cohorts (CTN 314)
Learn MoreEnrolling
Electronic capture through the Opal patient portal of a patient-reported measure of barriers to antiretroviral therapy adherence: a mixed method type 3 hybrid pilot study at a large Montreal HIV clinic
Learn MoreEnrolling
Reporting
BonE health in ageING Women: improvement or prevention of changes in bone mineral density by switching antiretroviral agents
Learn More